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A B S T R A C T
The anti-diabetic effect of isoflavone-rich kudzu extract obtained using natural deep eutectic solvent was as-
sessed in diabetic wistar rats treated at doses of 100 mg/kg or 200 mg/kg for 28 days. Effect of treatment was
based on weight, glucose tolerance, fasting glucose and glycated haemoglobin level, hepatic biochemical
parameters, expression of anti-insulin and Ki67 antibodies, and histopathological evaluation of pancreas and
kidney tissues. We found overall improvement in weight in diabetic rats treated with the extract at dose 200 mg/
kg, but not at dose of 100 mg/kg. Plasma level of alanine transaminase (ALT) and aspartate aminotransferase
(AST), but not alkaline phosphatase (ALP), were significantly different between untreated diabetic rats and those
treated with the extract (p = 0.05). We found that the isoflavones-rich extract stimulated β-cell regeneration in a
dose-dependent effect and showed no observable toxic impact in either the kidney or pancreas. Thus, this extract
may be a promising treatment option for diabetic condition.
1. Introduction
Diabetes mellitus (DM) is a metabolic disease plaguing a substantial
number of people, with a global estimate of approximately 424.9 mil-
lion people living with this disease in 2017 and expected upsurge to
628.6 million by 2045, these staggering figures makes this disease one
of the leading global hospital burden (IDF, 2017). DM can be chiefly
divided into two main types, type I diabetes mellitus (T1DM) and type 2
diabetes mellitus (T2DM). While T1DM is a disease characterized by the
total destruction of pancreatic β-cells, T2DM is marked by dysfunc-
tional pancreatic β-cells and insulin resistance (Aguayo-Mazzucato &
Bonner-Weir, 2018). Pancreatic β-cell function and mass play critical
role in the manifestation of this disease, thus the regeneration of lost
functional β-cell mass offers therapeutic strategy to alleviate the pro-
gression of this disease (Aguayo-Mazzucato & Bonner-Weir, 2018).
While the complexity of DM pathogenesis cannot be overstated, this
disease is characterized by hyperglycemia, a condition that could
possibly progress to advance consequences such as macrovascular
complications (coronary artery disease and peripheral arterial disease),
and microvascular complications (diabetic retinopathy, nephropathy,
and neuropathy) when left untreated (Fowler, 2008). Therefore, low-
ering glucose level is one of the pivots in the management of diabetes
(Fowler, 2008). Diabetic nephropathy (DN) has been highlighted as the
leading cause of end stage renal disease (ESRD), a condition which
could be fatal when left uncontrolled (Yaribeygi, Mohammadi, Rezaee,
& Sahebkar, 2018). The onset and progression of DN is marked by
functional and structural changes in kidney which include an increase
in albumin level, glomerular hyperfiltration, tubular atrophy, and ar-
teriolar hyalinosis (Lim, 2014). Advance consequences have plagued
the long-term use of most antidiabetic therapies used in clinical prac-
tice, hence, the need for sustainable solution remains a major concern
(Wareham & Herman, 2016). In preclinical studies, different chemicals
have been successfully used to induced diabetes, one of which is alloxan
monohydrate, this compound has been found to generate reactive
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oxygen species (ROS) which in turn results to the necrotic death of
pancreatic β-cells (Radenkovic, Stojanovic, & Prostan, 2016).
Dietary phytoestrogens, especially isoflavones, have been on the
limelight as potential antidiabetic therapeutics owing to their ability to
scavenge free radical, prevent inflammation, and lower blood glucose
level (Duru, Kovaleva, Danilova, Van der Bijl, & Belousova, 2018; Lee,
2006). Isoflavones are phytochemicals richly found in leguminous
plants (such as Glycine max and Pueraria lobata), these phytochemicals
share structural similarity with the human estrogen, thus exhibiting
potential health benefits by acting on estrogen receptors (Bhathena &
Velasquez, 2002). Chemical analysis of Pueraria lobata (popularly
known as kudzu) extract identified 3 main isoflavones namely puerarin,
daidzein, and genistein (Bebrevska, Theunis, Vlietinck, Pieters, & Apers,
2008). This extract has been widely used in Chinese traditional medi-
cine to treat diseases such as diarrhoea, diabetes, and cardiovascular
diseases (Wong, Li, Li, Razmovski-Naumovski, & Chan, 2011).
While most extraction techniques of isoflavones from raw sources
have been performed using conventional organic solvents which are
perceived to be non-environmentally friendly and toxic, the need to
develop green extraction solvents remains critical for the broad use of
isoflavones in pharmaceuticals (Bajkacz & Adamek, 2017). Natural
deep eutectic solvents (NADES), a class of green solvents that are syn-
thesized from natural metabolites, have shown promising advantages
over conventional solvents such as non-toxicity and biodegradability
(Choi et al., 2011). While these solvents have been applied in the ex-
traction of different bioactive compounds, only few studies have suc-
ceeded in extracting isoflavones using them (Bajkacz & Adamek, 2017;
Nam, Zhao, Lee, Jeong, & Lee, 2015).
This study investigates the antidiabetic properties of isoflavone-rich
extract obtained from kudzu roots using NADES in alloxan induced
diabetic rats. Evaluation of the antidiabetic properties of the isoflavone-
rich extract was based on key parameters such as glycemic control,
haematological indices, hepatic enzyme activities, and regeneration of
pancreatic β-cells. Furthermore, we explored the renal protective or
possible nephrotoxicity effect of the isoflavone-rich extract in diabetic
and healthy rats.
2. Materials and method
2.1. Materials
Daidzein, genistein, puerarin, vitexin, and 4-hydroxyflavanone
standards were purchased from Sigma Aldrich (Missouri, USA). Dried
kudzu roots were purchased from Xi'an Sgonek Biological Technology
(Shaanxi Sheng, China). Alloxan monohydrate was purchased from
Sigma Aldrich (Missouri, USA).
2.2. Preparation of natural deep eutectic solvent (NADES)
NADES comprising choline chloride and citric acid (1:2, mol/mol)
was prepared as described by Dai, Spronsen, Witkamp, Verpoorte, and
Choi (2013). Briefly, the calculated amount of choline chloride and
citric acid was transferred into a glass seal and 20% of distilled water
was added to the mixture. The mixture was heated at 60–80 °C under
constant stirring until a transparent solution was observed. The solution
was stored in dark until when used.
2.2.1. Extraction and quantification of isoflavones from kudzu roots
Extraction of isoflavones from dried kudzu root was carried out
using NADES at a solvent volume (mL) to material ratio (g) of 20:1.
Extraction was done in an ultrasonic bath at 50 °C for 3 h. The extract
was separated from the insoluble fractions by centrifugation (6000 rpm
for 30 mins), then concentrated to dryness using a rotary evaporator
and dissolved in methanol prior HPLC analysis. Isoflavone content of
the extract was analyzed as described by Bajkacz and Adamek (2017)
using an Agilent Zorbax SB-C18 (150 mm × 2.1 mm) column on the
Agilent 1100 series liquid chromatograph (consisting a pump, degasser,
autosampler, and UV/Vis detector). Samples were injected at a volume
of 250 µL. The binary mobile phase comprised water +2 mL/L formic
acid (solvent A) and acetonitrile (solvent B). A linear gradient elution of
solvent B was applied starting from 15% to 85% over 20 mins, at a flow
rate of 0.3 mL/min. The temperature of the column was kept at 35 °C.
Isoflavones were separated on a reversed stationary phase and detected
with UV at 254 nm. Daidzein, puerarin, and genistein were used as
standards, while vitexin, and 4-hydroxyflavanone were used as external
standards. Comparison of the retention and UV spectra of each in-
dividual isoflavone contained in the extract with those of pure stan-
dards was used for identification. Quantification of each isoflavone
content in the extract was done using calibration curves of average peak
areas of the standard solutions against the corresponding concentra-
tions as described by Kao and Chen (2002). The detection limit (DL)
and quantitation limit (QL) was determined in accordance to the
method described by the ICH (1996).
2.3. Experimental animals
Female Wistar rats (12-weeks old) of weight 205 ± 7 g showing no
disease symptoms were procured from the animal facility of the Ural
Branch of Russia Academy of Science (UB RAS) and used for the study.
The Animals were housed 5 per polypropylene cage under standard
laboratory conditions, 20 ± 2 °C, light: dark cycle (12 h:12 h). Rats
were fed with standard rat chow (Teklad 2016, Teklad diets, Madison,
WI, USA; 16.4% protein, 4.0% fat, 3.3% crude fibre, and 48.5% car-
bohydrate) and allowed free access to purified water. All the animal
experiment protocols were approved by the Animal Ethics Committee
of the Ural Branch of Russia Academy of Science (UB RAS). Rats were
Fig. 1a. Shows HPLC chromatogram of showing peaks of isoflavone standards.
Fig. 1b. Shows HPLC chromatogram of Isoflavone-rich extract obtained from
kudzu using NADES extract of kudzu root.
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Weight of rats was recorded weekly during the study.
2.4. Induction of diabetic and grouping
Diabetes was induced by a single intraperitoneal (i.p) injection of
freshly prepared alloxan monohydrate (170 mg/kg) after 16 h of
fasting. Prior injection, alloxan monohydrate was dissolved in 10 mM
sodium citrate (pH 4.5). Fasting blood glucose (FBG) level was mea-
sured 72 h after injection and rats with FBG level of ≥7.1 mmol/L were
selected as successfully prepared diabetic models and used in the study.
Rats were randomly divided into six groups, each group comprised
ten (n = 10) rats. The groups are as follows: NC group: healthy control
Table 1
Effect of isoflavone rich extract on body weight of experimental animals.
Experimental group 7 days 14 days 21 days 28 days
Control rats + vehicle (NC) 274 ± 14* 303 ± 15* 317 ± 17* 320 ± 17*
Control rats + isoflavone-rich kudzu root extract (100 mg/kg) (NC + Iso) 295 ± 27*a 311 ± 27*a 321 ± 29*a 327 ± 26*a
Control rats + isoflavone-rich kudzu root extract (200 mg/kg) (NC + Iso 200) 306 ± 26*a 327 ± 17*a 327 ± 14*a 331 ± 11*a
Diabetic control + vehicle (DM) 208 ± 10 200 ± 13 193 ± 5 190 ± 8
Diabetic + isoflavone-rich kudzu root extract (100 mg/kg) (DM + Iso) 208 ± 8 222 ± 21 222 ± 22 227 ± 17*
Diabetic + isoflavone-rich kudzu root extract (200 mg/kg) (DM + Iso 200) 217 ± 16 238 ± 22* 253 ± 19* 253 ± 19*
Data are shown as mean ± SD.
* Indicates significant difference compared to DM group in the same column (p < 0.05).
a Indicates no significant difference compared to NC group (p = 0.05).
Fig. 2. Depicts the effect of isoflavone-rich kudzu extract treatment in diabetic and healthy rats. Blood concentrations of (a): fasting glucose, (b): glycated hae-
moglobin (HbA1c). *indicates significant difference compared to DM group (p < 0.01); ^ indicates significant difference compared to NC group (p < 0.01).
Table 2
Effect of the isoflavone-rich extract on insulin level and oral glucose tolerance in diabetic animals.
Experimental group Blood glucose levels (mmol/L) AUC mmol/L/h
0 min 30 mins 60 mins 120 mins
Control rats + vehicle (NC) 4.9 ± 0.47 7.5 ± 0.32 5.7 ± 0.45 5.1 ± 0.51 11.8 ± 0.87
Diabetic control + vehicle (DM) 9.4 ± 1.17a 14.5 ± 0.76 a 12.3 ± 0.56a 12 ± 0.92a 24.8 ± 1.44a
Diabetic + isoflavone-rich kudzu root extract (100 mg/kg) (DM + Iso) 6.3 ± 0.95* 9.3 ± 0.47*a 7.7 ± 1.15*a 6.7 ± 0.67* 15.4 ± 1.67*a
Diabetic + isoflavone-rich kudzu root extract (200 mg/kg) (DM + Iso 200) 5.4 ± 0.47* 8.5 ± 0.32* 6.2 ± 0.45* 5.7 ± 0.51* 13.1 ± 0.9*
Data are shown as mean ± SD.
a Shows significant difference compared to NC group (p < 0.01).
* Shows significant difference compared to DM group (p < 0.01).
Table 3
Effect of isoflavone extract on liver and renal parameters.
Experimental group AST (U/L) ALT(U/L) ALP(U/L) Total protein (g/L) Urea (mmol/L)
Control rats + vehicle (NC) 13.4 ± 1 9 ± 2.2 51.3 ± 5.3b 69.5 ± 3.1 5.03 ± 0.06
Control rats + isoflavone-rich kudzu root extract (100 mg/kg) (NC + Iso) 15.2 ± 4.2* 8.6 ± 6.2* 35.6 ± 8.8b 72.9 ± 3.6* 3.6 ± 0.6*
Control rats + isoflavone-rich kudzu root extract (200 mg/kg) (NC + Iso) 15.3 ± 1.3* 7.2 ± 2.1* 34.7 ± 7.9b 73.6 ± 6.4* 3.1 ± 0.3*a
Diabetic control + vehicle (DM) 21 ± 2.4a 16.3 ± 2.6 a 63.4 ± 26.4b 59.1 ± 3.9 a 8.2 ± 1.2 a
Diabetic + isoflavone-rich kudzu root extract (100 mg/kg) (DM + Iso) 15.6 ± 1.74* 8.3 ± 1.9* 62.8 ± 4b 73.0 ± 3.5* 4.8 ± 0.3*
Diabetic + isoflavone-rich kudzu root extract (200 mg/kg) (DM + Iso 200) 14.9 ± 2.1* 7.9 ± 1.4* 58.7 ± 6.5b 71.5 ± 2.9* 4.9 ± 0.6*
Data are shown as mean ± SD.
a Shows significant difference compared NC group (p < 0.01).
* Shows significant difference compared to DM group (p < 0.01).
b Shows no significant difference between groups (p ≥ 0.05).
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rats + vehicle (distilled water), NC + Iso group: healthy control
rats + isoflavone-rich kudzu root extract (100 mg/kg), NC + Iso 200
group: healthy control rats + isoflavone-rich kudzu root extract
(200 mg/kg), DM group: diabetic control rats + vehicle , DM + 1so
group: diabetic rats + isoflavone-rich kudzu root extract (100 mg/kg),
DM+ 1so 200 group: diabetic rats + isoflavone-rich kudzu root extract
(200 mg/kg). The isoflavone-rich extract was dissolved in distilled
water and administered via oral gavage; animals were treated thrice
weekly during the 28 experimental days. Treatment of rats in each
classified group was initiated 4 days after alloxan monohydrate injec-
tion.
Fasting blood glucose, glycosylated hemoglobin (HbA1c), and
oral glucose tolerance test (OGTT)
At the end of the study, all rats were fasted, and blood was collected
via cardiac puncture. FBG level was determined using glucose oxidase
method as described by Danilova et al. (2017), and glycosylated he-
moglobin (HbA1c) measured using affinity chromatography (TOR
9398240-16404416-01, Fosfosorb OJSC, Russian Federation) according
to Jeppsson et al. (2002). Assessment of oral glucose tolerance test
(OGTT) of rats in NC, DM and DM+ Iso, and DM+ Iso 200 group, was
done using a OneTouch glucometer (LifeScan, Wayne, PA, USA. This
assessment was based on the FBG level at 0 min, and postprandial
glucose (PG) level measured after oral administration of glucose (2 g/
kg) at 30, 60, and 120 min. The area under the curve (AUC) were
calculated according to Sakaguchi et al. (2016) using the trapezoidal
approximation of PG levels.
2.5. Evaluation of hepatic and renal parameters
Plasma level of ALT, AST, ALP, urea, and total protein were de-
termined using ready to use reagents kits (Vital diagnostics, St.
Petersburg) as described by Ostroushko et al. (2013). Tests were con-
ducted using a DU-800 spectrophotometer (Beckman Coulter Int. S.A.,
Switzerland) at specified wavelength according to manufacturers.
2.6. Determination of haematological parameters
White blood cell (WBC), Mean platelet volume (MPV), platelet
distribution width (PDW), plateletcrit (PCT), and platelet count (PLT)
were estimated using automated haematology analyzer (Biocode Hycel,
France) with heparinized blood samples.
2.7. Histological and immunohistochemical study
Rats were euthanized by cervical dislocation, and the kidney and
pancreas were excised and fixed in 10% formalin. Tissues were pro-
cessed using a tissue processor (Leica TP 1020) and embedded in par-
affin blocks. Approximately 3–4 µm sections of kidney and pancreas
tissue were stained with hematoxylin and eosin (H&E) dye, kidney
tissue sections were additionally stained with periodic acid schiff (PAS)
dye.
Immunohistochemical detection of anti-insulin and Ki67 antibodies
in pancreatic tissues was done as per the avidin–biotin peroxidase
complex (ABC) method. Briefly, tissue sections were deparaffinized and
incubated in antigen retrieval buffer (0.01 M citrate buffer, pH 6.0) for
15 min at 95 °C. Afterwards, tissue sections were incubated with pri-
mary antibody for insulin (clon E11D7, Millipore; diluted at 1:200) or
Ki67 (Leica, Biosystems; diluted at 1:25), overnight at 4 °C. Tissue
sections were further incubated in Biotinylated secondary antibody for
1 h at room temperature. All tissue sections were examined under light
microscope (Leica DM 2500) using ×40 magnification objective.
2.8. Morphometric analysis
The total number of islets and number of islets showing positive
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counted. We estimated the percentage of β-cells in each individual islet
based on the total number of islet cells and those showing positive in-
sulin staining (brown stain). The insulin content in β-cells was assessed
based on the optical density of the stained cells using the image analysis
software Video Test “Morphology” 5.0. All morphometric evaluations
were based on 20–30 microscopy field per tissue section of each rats.
2.9. Statistical analysis
Statistical analysis was performed using Statistica 6.0 (StatSoft, Inc).
Data were presented as mean ± SD based on 3 independent measure-
ments, and significant difference between group was considered at
P < 0.05 or 0.01. Data were analyzed by one-way ANOVA and
Dunnett's T test.
3. Results
3.1. Identification and quantification of isoflavones content in kudzu root
extract
The HPLC chromatogram showing peaks of isoflavone standards
used in the current study was presented in Fig. 1a. The HPLC analysis
showed that the obtained kudzu root extract contains daidzein, genis-
tein, and puerarin (Fig. 1b). Quantification of the individual isoflavone
content of the extract showed that the extract contained 3.69 ± 0.02%
puerarin (36.9 mg/g of extract), 0.27 ± 0.005% daidzein (2.7 mg/g of
extract), and 0.037 ± 0.001% genistein (0.4 mg/g of extract), respec-
tively. This implied that 2.5 g and 5 g of the extract contained 100 mg
and 200 mg of total isoflavones, respectively.
3.2. Effect of isoflavone-rich kudzu root extract on body weight
As shown in Table 1, an approximately 8.7% decrease in weight was
observed in the DM group during the study, this weight loss was
ameliorated in diabetic rats treated with the isoflavone-rich extract at
dose of 200 mg/kg. However, this could not be said when diabetic rats
treated with the isoflavone-rich extract at dose of 100 mg/kg as no
significant improvement in weight was observed, not until the 4th ex-
perimental week. As presented in Table 1, we found no significant
difference (p = 0.05) between weight of healthy control rats (NC
group) and healthy rats treated with the isoflavone-rich extract
(NC + Iso and NC + Iso 200 group)
3.3. Influence of the isoflavone-rich kudzu root extract on blood glucose,
oral glucose tolerance, and glycated haemoglobin
As depicted in Fig. 2a, we found that the isoflavone-rich kudzu
extract had no advance effect on glycemic control as FBG level mea-
sured in healthy control rats (NC group) and healthy rats treated with
the isoflavones-rich extract (NC+ Iso and NC+ Iso 200 group) was not
significantly different (p = 0.05) . As illustrated in Fig. 2a, FBG level
was significantly elevated in diabetic rats compared to healthy control
rats, this elevated level was found to decrease in a dose-dependent
manner with the administration of the isoflavone-rich extract , with a
significant difference only observed at a treatment dose of 200 mg/kg
(DM + Iso 200 group). Similarly, as presented in Fig. 2b, a pronounced
elevation in HbA1c level was observed in DM group compare with NC
group (p < 0.05), this was also significantly decreased in a dose-de-
pendent manner in with the isoflavone-rich extract treatment. We ob-
served no significant difference in HbA1c levels between NC, NC + Iso,
and NC + Iso 200 group (p = 0.05).
As shown in Table 2, diabetic rats showed poor glucose tolerance,
this was visible from higher AUC value observed in DM group as
compared to NC group (p < 0.05). When compared to DM group,
DM + Iso and DM + Iso 200 group showed improved glucose toler-
ance, this was evident from their lower AUC values (Table 2). We ob-
served that the AUC value of NC group and DM+Iso 200 did not sig-
nificantly differ (p = 0.05).
3.3.1. Effect of isoflavone rich kudzu root extract on hepatic and renal
biochemical parameters
As presented in Table 3, there was increase in the serum level of AST
and ALT in DM group compare with NC group (p < 0.05). The treat-
ment of diabetic rats with the isoflavone-rich extract lowered the AST
and ALT levels (Table 3). No significant difference was observed in
serum ALP level in rats of all experimental groups (p = 0.05).
As shown in Table 3, a marked decrease in total protein and increase
in serum urea level was observed in DM group as compared to NC group
(p < 0.05). The treatment of diabetic animals with the isoflavone-rich
extract improved total protein level, from 59.1 ± 3.9 g/L observed in
DM group to 73.0 ± 3.5 and 71.5 ± 2.9 in DM + Iso and DM + Iso
200, respectively (Table 3). The treatment of diabetic rats with the
isoflavone-rich extract significantly lowered the serum urea level from
8.2 ± 1.2 mmol/L observed in DM group to 4.8 ± 0.3 mmol/L and
4.9 ± 0.6 mmol/L in DM + Iso and DM + Iso 200, respectively
(Table 3).
3.4. Influence of isoflavone rich extract on haematological parameters
Data presented in Table 4 show no significant difference in WBC,
MPV, and PDW level between the experiment groups (p = 0.05).
However, an elevated PLT count and PCT level was observed in DM
group as compared to NC group (p < 0.05). This elevated PLT count
was found to be significantly lower (p < 0.05) in diabetic rats treated
with the isoflavone-rich extract at doses of 200 mg/kg (DM + Iso 200
group). No significant difference was observed between the PLT count
in DM group and DM+ Iso group (p = 0.05). The treatment of diabetic
rats with the isoflavone-rich extract showed no effect on the PCT level
as no significant difference was observed with treatment at both doses
(p = 0.05). The level of PCT and PLT count was insignificantly different
between NC, NC + Iso, and NC + Iso200 group (Table 4).
3.5. Histological evaluation of pancreatic islets
Normal distribution of noncapsulated, oval or rounded pancreatic
islets with well-defined boundaries was observed in NC + Iso and
NC + Iso 200 group (Fig. 3a), which were histological similar to the
pancreatic tissues observed in NC group. As presented in Fig. 3a, irre-
gular shaped pancreatic islets with pronounced reduction was observed
in DM group, these structural alterations were ameliorated in diabetic
rats treated with isoflavone-rich extract (DM + Iso and DM + Iso 200
group). It could be suggested that the treatment with the isoflavone-rich
Fig. 3. Light microscopic pictures of pancreas sections. (a) Hematoxylin and eosin staining ×400; NC group showing normal structure of the Islets of Langerhans
(arrow) and acini(star); NC + Iso group showing normal structure of the Islets of Langerhans (arrow) and acini(star); NC + Iso 200 group showing normal structure
of the Islets of Langerhans (arrow) and acini(star); DM group showing degeneration of the islet (arrow); DM + Iso group showing preservation of the architectural
structure of Islet of Langerhans (arrow); DM+ Iso 200 group showing restoration of the architectural structure of Islet of Langerhans (arrow), acini (star). (b) Insulin
immunostaining (brown colour) ×400; NC group showing intense insulin-positive β cells; NC + Iso group showing high number of insulin positive β cells (brown
colour); NC + Iso200 group showing high intense insulin positive β cells (brown colour); DM group showing a decreased number of insulin-positive β cells; DM+ Iso
and DM + Iso 200 group showing an increased number of insulin-positive β cells as compared to the DM group. (c) Ki67 immunostaining ×400, ki67-positive cells
are identified by their brown colour (arrow). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this
article.)
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extract somehow prevented further degradation of the pancreatic islets
after the induction diabetes.
3.6. Immunohistochemical and morphometric analysis
Based on the data presented in Table 5 and Fig. 3b, we observed that
when compared to NC group, DM group showed markedly reduction in
percentages of islets with insulin positive response and β-cells per total
number of islet cells (p < 0.05), the number of pancreatic islets per
field (N/mm2) was also decreased. No significant difference was ob-
served between NC, NC + Iso and NC + Iso 200 group based on the
number of pancreatic islets per field (N/mm2), percentages of islets
with positive insulin response and β-cells per total islet cells (Table 5,
Fig. 3b). Although no significant difference was observed between DM
and DM + Iso group in terms of number of pancreatic islets per field
(N/mm2) (p = 0.05) , but at treatment dose of 200 mg/kg (DM + Iso
200 group), the isoflavone-rich extract was found to enhance the
number of pancreatic islets per field (N/mm2) (Table 5).
Also, the treatment of diabetic animal with the isoflavone-rich ex-
tract (DM + Iso and DM + Iso 200 group) increased the number
pancreatic β -cells compared with DM group (Table 5 and Fig. 3b). The
percentage of β-cells per the total number of islet cells was found to
increase from 47.4 ± 12% observed in DM group to 62.8 ± 11.8 and
68.8 ± 9.1 in DM and DM+ Iso group, respectively. The percentage of
pancreatic islets with positive insulin response was also enhanced in
diabetic animals treated with the isoflavone extract in a dose-dependent
manner with 95 ± 2% and 92 ± 3% of insulin positive pancreatic islet
recorded in DM+ Iso 200 and DM+ Iso, respectively. Interestingly, no
difference was observed in the insulin content in β -cells in all groups as
the intensity of immunostained insulin positive pancreatic cells be-
tween did not differ in all experimental groups (p = 0.05).
We noticed that the treatment of normal control animals with the
isoflavone-rich kudzu extract at both doses (NC + Iso and NC + Iso
200 group) significantly increased the number of Ki67 positive cells in
the pancreatic islets as compared to normal control animals (Fig. 3c,
Table 5). An observable decrease in the number of Ki67 positive cells
was found in diabetic group which was significantly enhanced by iso-
flavone-rich kudzu extract treatment at dose of 200 mg/kg (Fig. 3c,
Table 5). Although the treatment of diabetic rat with the isoflavone-rich
kudzu extract at dose of 100 mg/kg increased the expression of Ki67
positive cells in the pancreatic islets, no significant difference was
found compared to DM group (Fig. 3c, Table 5).
3.7. Histopathological evaluation of kidney sections of experimental groups
As illustrated in Fig. 4, abnormal glomerular capillary network and
hypercellularity was observed in kidney sections from DM group com-
pared with NC group. These alterations were remediated in diabetic rats
treated with the isoflavone-rich extract (DM + Iso and DM + Iso 200
group), as decrease in the cellularity of the glomerulus (the number of
mesangial, podocytes, and endothelial cells), and restoration of the
histological structure of the glomerular capillary network, were ob-
served (Fig. 4). Furthermore, the treatment of healthy rats with the
isoflavone-rich extract (NC + Iso, NC + Iso 200 group) showed normal
cellularity and histological structure of glomerulus, similar to those
observed in NC group (data not shown). As depicted in Fig. 5, normal
cubical simple epithelium cells and brush border of the renal tubules
was observed in NC group which were found to be mildly damaged
(damage to the proximal convoluted tubules) in DM group. The treat-
ment of healthy rats with the isoflavone-rich extract at both doses
showed no nephrotoxic effect, nor alteration of the renal tubules
(Fig. 5).
4. Discussion
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assessed based on effect on glycemic control, liver biomarkers, hae-
matological indices, and expression of insulin and Ki-67 antibody. We
observed that the isoflavone-rich extract can potentially improve gly-
cemic control and stimulate the regeneration of pancreatic β-cells, in a
dose-dependent manner. The treatment of diabetic rats with the iso-
flavone-rich extract also ameliorated abnormal circulating level of liver
biomarkers (such as AST, ALT, ALP, and Urea) associated with diabetes
pathogenesis. Overall, we found that the isoflavone-rich extract had no
effect on haematological parameters. Additionally, at both treatment
doses, the isoflavone-rich extract did not show any characteristic ne-
phrotoxic effect in healthy rats, rather it exhibited renal protective ef-
fect when administered to diabetic rats.
Based on HPLC analysis, we identified three types of isoflavones
(puerarin, daidzein and genistein) in the isoflavone-rich kudzu root
extract. The isoflavone having the highest content in the isoflavone-rich
extract was puerarin (3.69 ± 0.02%) and the least was genistein
(0.037 ± 0.001%). This finding supports previous study where puer-
arin and daidzein were identified in extract obtained from kudzu root,
and the same authors found the obtained extract to contain higher
percentage of puerarin (Kitada, Mizobuchi, Ueda, & Nakazawa, 1985).
We observed progressive weight loss in DM group. Our finding
supports previous study where pronounced decrease in body weight has
been reported in diabetic animals (Oza & Kulkarnia, 2018a). The
treatment of diabetic rats with the isoflavone-rich extract at dose of
200 mg/kg, improved body weight starting from the 2nd experimental
week. From our findings, we observed overall improvement in glycemic
control (OGTT, FBG, and HbA1c) in diabetic rats treated with the iso-
flavone-rich extract, in a dose-dependent manner. Previous studies re-
ported on the excellent ability of soy isoflavones to lower blood glucose
level when administered to STZ- induced animals (Lee, 2006; Shim,
Kim, Seo, & Lee, 2007). Contrastingly, authors found increased levels of
serum insulin and GSH concentration, and reduction in blood glucose
level and methylglyoxal concentration when diabetic rats were treated
with high isoflavone dose (550 mg/kg), while at low treatment doses
(of 120 mg/kg),no positive effect was observed (Lu et al., 2008). Si-
milarly, authors found no positive influence on the glycemic control in
T2DM postmenopausal women treated with isoflavone supplementa-
tion at 132 mg/day (González, Jayagopal, Kilpatrick, Chapman, &
Atkin, 2007). Although authors reported that at low dietary doses (240,
480, and 1920 mg/100 g diet), isoflavone did not lower blood glucose
levels in diabetic animals (Hsu, Chiu, & Yeh, 2003), other studies found
that the treatment of STZ induced animals with soy isoflavones (at dose
of ≤600 mg/kg diet) lowered blood glucose level (Lee, 2006; Shim
et al., 2007). Authors found that the treatment of diabetic animals with
genistein improved glycemic control (Rehman, Ali, & Akash, 2019), and
the treatment of same animals with formononetin and biochanin A,
both isoflavones, also decreased HbA1c level and improve overall gly-
cemic control (Oza & Kulkarnia, 2018a, 2018b). It could be suggested
NC Group DM Group 
DM+Iso Group DM+Iso 200 Group
Fig. 4. Showing the effect of isoflavone-rich kudzu extract on histological changes in the glomerulus (a): NC group showing normal glomerular capillary network
with podocytes and mesangial cells (arrow); (b): DM group showing hypercellularity of glomerulus, and mesangial cells proliferation (arrow); (c): DM + Iso group
showing normal structure of glomerular capillary network with normal cellularity of the glomeruls (arrow); (d): DM + Iso 200 group showing normalcellularity of
glomerulus (arrow).
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that the improvement in weight observed in diabetic rats treated with
the isoflavone-rich extract might be a result of overall improvement in
glycemic control.
Abnormal expression of liver enzymes such as, ALT, AST, and ALP
has been associated with the manifestation of diabetes, thus level of
these enzymes serve as vital indicators (Fernandes, Novelli, Fernandes
Junior, & Galhardi, 2009; Tibi, Collier, Patrick, Clarke, & Smith, 1988).
We observed that the elevated AST and ALT recorded in diabetic rats
were lowered when treated with the isoflavone-rich kudzu extract at
both doses. Similarly, authors reported that the oral administration of
diabetic rats with biochanin A decreased the level of AST and ALT
(Azizi, Goodarzi, & Salemi, 2014). The isoflavone-rich kudzu extract
was also found not to negatively affect the activities of the liver en-
zymes in normal healthy rats. Interestingly, we found that serum level
of ALP did not differ between experimental groups despite previous
study reporting otherwise (Azizi et al., 2014). Authors also observed no
significant difference between serum ALP level in diabetic and control
subjects suggesting that there was no strong correlation between ALP
levels and the manifestation of diabetes (Chen et al., 2017). However, it
could be suggested that the short study duration could be the under-
lying reason for this effect.
Circulating urea and protein level are another valuable assessment
tool in the diagnosis and management of diabetes (Chutani & Pande,
2017; Hasan & Abdulsattar, 2015; Xie et al., 2018). We found an overall
improvement in both serum protein and urea level in diabetic rats
treated with the isoflavone-rich kudzu extract compared to the un-
treated diabetic rats. Similarly, authors reported that the consumption
of soy isoflavones decreased urinary albumin excretion and improved
the total protein in diabetic nephropathy patients (Teixeira et al.,
2004), and a 60 days treatment of insulin resistant rats with genistein
decreased serum urea, and attenuated renal damage (Palanisamy,
Viswanathan, & Anuradha, 2008). Also, it was reported that the treat-
ment of STZ-induced diabetic rats with isoflavones-rich extract from
Pueraria tuberosa tubers reduced level of serum urea (Tripathi, Shukla,
Pandey, Pandey, & Kumar, 2017). We found no significant difference in
serum protein and urea level in healthy rats and those treated with the
isoflavone-rich extract. This could imply that the isoflavone-rich extract
had no advance effect in protein metabolism even at high dose of
200 mg/kg.
Increase level of hematological indices such as WBC, MPV, PDW,
PCT, and PLT count, have been implicated in diabetes complications
(Demirtas et al., 2015; Kim et al., 2014; Twig et al., 2013). However, we
found that WBC, MPV, and PDW did not significantly differs between
diabetic and healthy rats. This contradicts previous study where sig-
nificant difference in level of WBC, MPV, and PDW were reported be-
tween healthy and diabetic rats (Demirtas et al., 2015). It could be
suggested that the study duration (28 days) was rather short to result in
varying level of WBC, MPV, and PDW in experimental animals. How-
ever, we found an increase in PLT count and decrease in PCT levels in
diabetic rats which were slightly ameliorated when treated with the
isoflavones-rich extract. The isoflavones-rich extract had no advance
effect on PLT count and PCT level in healthy rats. Authors found that
supplementation of postmenopausal women’s diet with soy showed no
advance effect on PLT count and PCT level (Soung et al., 2006).
The loss of function and mass of pancreatic β-cells has been one of
the major highlights in the pathogenesis of type 2 diabetes mellitus,
making regeneration of these cells a possible therapeutic approach. We
noticed that the treatment of diabetic rats with the isoflavone-rich ex-
tract at both doses stimulated the regeneration of β-cells, this was
evident from the increase in the number of insulin and Ki-67 (pro-
liferation marker) positive cells observed in DM and DM + Iso 200
group compared to the DM group. Authors reported that the treatment
of diabetic rats with puerarin preserved pancreatic β-cell mass and
maintained the pancreatic insulin content (Yaribeygi et al., 2018; Li
et al., 2014; Yang & Kang, 2018). Previous study also found that the
treatment of HFD and db/db mice with puerarin stimulated the pro-
liferation of Ki-67/β-cells (Yang et al., 2016). Also, it was reported that
the treatment of diabetic animals with formononetin (an isoflavone)
ameliorated pancreatic tissue damage (Oza & Kulkarnia, 2018a).
Diabetes mellitus has been implicated as the most leading cause of
NC group NC +Iso group 
puorg002osI+CNpuorgMD
Fig. 5. Histological evaluation of renal tubules
and renal corpuscle of experimental groups
(×400 PAS staining). (a): NC group showing
Normal epithelial cells and brush border of the
proximal convoluted tubules; (b): NC + Iso
group showing no nephrotoxic effect, normal
epithelial cells and brush border of the proximal
convoluted tubules; (c): DM group showing da-
mage to the proximal convoluted tubules; (d):
NC + Iso 200 group showing Normal cellularity
of glomerulus, normal epithelial cells and brush
border of the proximal convoluted tubules.
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chronic renal disorders which usually manifests as histological changes
of the kidney and alteration of its functions (Lim, 2014). Based on the
histological evaluations of kidney tissues, we found that the iso-
flavones-rich extract can potentially ameliorate renal damage resulting
from diabetes. Previously, authors found that treatment of diabetic
animals with formononetin inhibited degenerative changes in kidney
tissues (Oza & Kulkarnia, 2018a). Similarly study also that 8 weeks
treatment of STZ-induced diabetic nephropathy mice with puerarin
restored the glomerular structure and reduced dilatation of the renal
tubules as compared to untreated diabetic animals (Xu et al., 2016).
Although this study was not aimed at comparing the antidiabetic
properties of the isoflavone-rich extract obtained using different ex-
tracting solvents, it remains worthy to state that previous study found
higher radical scavenging activity in Flos sophorae extract obtained
using NADES compared with extract obtained using methanol (Nam
et al., 2015). Despite a plethora of overwhelming preclinical findings, it
was reported that 8 weeks treatment of Ovariectomized (OVX) mice
with ethanol extract obtained from kudzu root showed no significant
improvement on insulin secretion and serum leptin level, although
blood glucose lowering effect was observed with the extract treatment
(Tanaka et al., 2016). This could suggest that extraction solvent might
have influence in the biological activities of different extracts. We
highly recommend comparative preclinical studies devoted to eluci-
dating the antidiabetic effect of isoflavone-rich extract obtained using
different solvents.
5. Conclusion
The current study evaluates the anti-diabetic effect of isoflavone-
rich extract obtained from dried kudzu root using natural deep eutectic
solvent, and it was found that this extract reduced hyperglycemia and
HbA1c level, enhanced glucose tolerance, and stimulated the re-
generation of pancreatic β-cells. Furthermore, it was revealed that this
isoflavones-rich extract can ameliorate potential liver injuries/damage
and prevent possible alteration in histological structure and function of
the kidney associated with diabetes pathogenesis. Additionally, we
found no nephrotoxic effect when healthy animals were treated with
this isoflavone-rich extract.
6. Ethics statements
All the animal protocols were approved by the ethical committee of
institute of Immunology and Physiology of RAS, Ural branch.
Funding
This work was supported by the Russian Science Foundation RSF
(Grant 16‐15‐000390‐П). Lab Wistar rats housing and care was sup-
ported by the IIP UrB RAS theme # AAAA-A18-118020590107-0.
Declaration of Competing Interest
The authors declare that they have no known competing financial
interests or personal relationships that could have appeared to influ-
ence the work reported in this paper.
Appendix A. Supplementary material
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.jff.2020.103922.
References
Aguayo-Mazzucato, C., & Bonner-Weir, S. (2018). Pancreatic beta cell regeneration as a
possible therapy for diabetes. Cell Metabolism, 27, 57–67. https://doi.org/10.1016/j.
cmet.2017.08.007.
Azizi, R., Goodarzi, M. T., & Salemi, Z. (2014). Effect of Biochanin A on serum visfatin
level of streptozocin-induced diabetic rats. Iran Red Crescent Medical Journal, 16,
e15424. https://doi.org/10.5812/ircmj.15424.
Bajkacz, S., & Adamek, J. (2017). Evaluation of new natural deep eutectic solvents for the
extraction of isoflavones from soy products. Talanta, 168, 329–335. https://doi.org/
10.1016/j.talanta.2017.02.065.
Bebrevska, L., Theunis, M., Vlietinck, A., Pieters, L., & Apers, S. (2008). Optimization and
validation of an HPLC method for quality control of Pueraria lobata root. Natural
Product Communications, 3, 2021–2027.
Bhathena, S. J., & Velasquez, M. T. (2002). Beneficial role of dietary phytoestrogens in
obesity and diabetes. American Journal of Clinical Nutrition, 76, 1191–1201. https://
doi.org/10.1093/ajcn/76.6.1191.
Chen, S. C. C., Tsai, S. P., Jhao, J. Y., Jiang, W. K., Tsao, C. K., & Chang, L. Y. (2017). Liver
fat, hepatic enzymes, alkaline phosphatase and the risk of incident type 2 diabetes: A
prospective study of 132,377 adults. Scientific Reports, 7, 4649. https://doi.org/10.
1038/s41598-017-04631-7.
Choi, Y. H., Van Spronsen, J., Dai, Y., Verberne, M., Hollmann, F., Arends, I. W., ...
Verpoorte, R. (2011). Are natural deep eutectic solvents the missing link in under-
standing cellular metabolism and physiology? Plant Physiology, 156, 1701–1705.
https://doi.org/10.1104/pp.111.178426.
Chutani, A., & Pande, S. (2017). Correlation of serum creatinine and urea with glycemic
index and duration of diabetes in Type 1 and Type 2 diabetes mellitus: A comparative
study. National Journal of Physiology, Pharmacy and Pharmacology, 7, 914–919.
https://doi.org/10.5455/njppp.2017.7.0515606052017.
Dai, Y., Spronsen, J., Witkamp, G. J., Verpoorte, R., & Choi, Y. H. (2013). Natural deep
eutectic solvents as new potential media for green technology. Analytica Chimica
Acta, 766, 61–68. https://doi.org/10.1016/j.aca.2012.12.019.
Danilova, I. G., Bulavintceva, T. S., Gette, I. F., Medvedeva, S. Y., Emelyanov, V. V., &
Abidov, M. T. (2017). Partial recovery from alloxan-induced diabetes by sodium
phthalhydrazide in rats. Biomedicine & Pharmacotherapy, 95, 103–110. https://doi.
org/10.1016/j.biopha.2017.07.117.
Demirtas, L., Degirmenci, H., Akbas, E. M., Ozcicek, A., Timuroglu, A., Gurel, A., &
Ozcicek, F. (2015). Association of hematological indicies with diabetes, impaired
glucose regulation and microvascular complications of diabetes. International Journal
of Clinical and Experimental Medicine, 8, 11420–11427.
Duru, K. C., Kovaleva, E. G., Danilova, I. G., Van der Bijl, P., & Belousova, A. V. (2018).
The potential beneficial role of isoflavones in Type 2 Diabetes mellitus. Nutrition
Research, 59, 1–15. https://doi.org/10.1016/j.nutres.2018.06.005.
Fernandes, A. H., Novelli, E. L. B., Fernandes Junior, A., & Galhardi, C. M. (2009). Effect
of naringerin on biochemical parameters in the streptozotocin-induced diabetic rats.
Brazilian Archives of Biology and Technology, 52, 51–59. https://doi.org/10.1590/
S1516-89132009000100007.
Fowler, M. J. (2008). Microvascular and macrovascular complications of diabetes. Clinical
Diabetes, 26, 77–82. https://doi.org/10.2337/diaclin.26.2.77.
González, S., Jayagopal, V., Kilpatrick, E. S., Chapman, T., & Atkin, S. L. (2007). Effects of
isoflavone dietary supplementation on cardiovascular risk factors in type 2 diabetes.
Diabetes Care, 30, 1871–1873. https://doi.org/10.2337/dc06-1814.
Hasan, H. R., & Abdulsattar, A. (2015). Influence of diabetes disease on concentration of
total protein, albumin and globulins in saliva and serum: A comparative study. Iraqi
National Journal of Chemistry, 15, 1–11.
Hsu, C. S., Chiu, W. C., & Yeh, S. H. (2003). Effects of soy isoflavone supplementation on
plasma glucose, lipids and antioxidant enzyme activities in streptozotocin-induced
diabetic rats. Nutrition Research, 23, 67–75.
International Conference on Harmonization, Guideline on the Validation of Analytical
Procedures: Methodology. 1996, Q2B.
International Diabetes Federation: Diabetes Atlas 8th edition. 2017, 1–2.
Jeppsson, J. O., Kobold, U., Barr, J., Finke, A., Hoelzel, W., Hoshino, T., ... Weykamp, C.
(2002). Approved IFCC reference method for the measurement of HbA1c in human
blood. Clinical Chemistry and Laboratory Medicine, 40, 78–89. https://doi.org/10.
1515/CCLM.2002.016.
Kao, T. H., & Chen, B. H. (2002). An improved method for determination of isoflavones in
soybean powder by liquid chromatography. Chromatographia, 56, 423–430.
Kim, Y. G., Suh, J. W., Yoon, C. H., Oh, I. Y., Cho, Y. S., Youn, T. J., ... Choi, D. (2014).
Platelet volume indices are associated with high residual platelet reactivity after
antiplatelet therapy in patients undergoing percutaneous coronary intervention.
Journal of Atherosclerosis and Thrombosis, 21, 445–453. https://doi.org/10.5551/jat.
20156.
Kitada, Y., Mizobuchi, M., Ueda, Y., & Nakazawa, H. (1985). Analysis of isoflavones in
Puerariae radix by high-performance liquid chromatography with amperometric
detection. Journal of Chromatography A, 347, 438–442.
Lee, J. S. (2006). Effects of soy protein and genistein on blood glucose, antioxidant en-
zyme activities, and lipid profile in streptozotoc-induced diabetic rats. Life Sciences,
79, 1578–1584.
Li, Z., Shangguan, Z., Liu, Y., Wang, J., Li, X., Yang, S., & Liu, S. (2014). Puerarin protects
pancreatic β-cell survival via PI3K/Akt signaling pathway. Journal of Molecular
Endocrinology, 53, 71–79. https://doi.org/10.1530/JME-13-0302.
Lim, A. K. H. (2014). Diabetic nephropathy- complications and treatment. International
Journal of Nephrology and Renovascular Disease, 7, 361–381.
Lu, M. P., Wang, R., Song, X., Wang, X., Wu, L., & Meng, Q. H. (2008). Modulation of
methylglyoxal and glutathione by soybean isoflavones in mild streptozotocin-induced
diabetic rats. Nutrition, Metabolism & Cardiovascular Diseases, 18, 618–623.
Nam, M. W., Zhao, J., Lee, M. S., Jeong, J. H., & Lee, J. (2015). Enhanced extraction of
bioactive natural products using tailor-made deep eutectic solvents: Application to
flavonoid extraction from Flossophorae. Green Chemistry, 17, 1718–1727.
Ostroushko, A. A., Gette, I. F., Medvedeva, S. Y., Danilova, I. G., Mukhlynina, E. A.,
Tonkushina, M. O., & Morozova, M. V. (2013). Study of acute and subacute action of
K.C. Duru, et al. Journal of Functional Foods 68 (2020) 103922
10
iron-molybdenum nanocluster polyoxometalates. Nanotechnologies in Russia, 8,
672–677. https://doi.org/10.1134/S1995078013050108.
Oza, M. J., & Kulkarnia, Y. A. (2018a). Formononetin treatment in type 2 diabetic rats
reduces insulin resistance and hyperglycemia. Frontiers in Pharmacology, 9, 739.
https://doi.org/10.3389/fphar.2018.00739.
Oza, M. J., & Kulkarnia, Y. A. (2018b). Biochanin A improves insulin sensitivity and
controls hyperglycemia in type 2 diabetes. Biomedicine & Pharmacotherapy, 107,
1119–1127. https://doi.org/10.1016/j.biopha.2018.08.073.
Palanisamy, N., Viswanathan, P., & Anuradha, C. V. (2008). Effect of Genistein, a Soy
Isoflavone, on Whole Body Insulin Sensitivity and Renal Damage Induced by a High-
Fructose Diet. Renal Failure, 30, 645–654. https://doi.org/10.1080/
08860220802134532.
Radenkovic, M., Stojanovic, M., & Prostan, M. (2016). Experimental diabetes induced by
alloxan and streptozotocin: The current state of art. Journal of Pharmacological and
Toxicological methods, 78, 13–31.
Rehman, K., Ali, M. B., & Akash, M. S. H. (2019). Genistein enhances the secretion of
glucagon-like peptide-1 (GLP-1) via downregulation of inflammatory responses.
Biomedicine & Pharmacotherapy, 112, 108670. https://doi.org/10.1016/j.biopha.
2019.108670.
Sakaguchi, K., Takeda, K., Maeda, M., Ogawa, W., Sato, T., Okada, S., Ohnishi, Y.,
Nakajima, H., & Kashiwagi, A. (2016). Glucose area under the curve during oral
glucose tolerance test as an index of glucose intolerance. Diabetology International, 7,
53–58. https://doi.org/10.1007/s13340-015-0212-4.
Shim, J. Y., Kim, K. O., Seo, B. H., & Lee, H. S. (2007). Soybean isoflavone extract im-
proves glucose tolerance and raises the survival rate in streptozotocin-induced dia-
betic rats. Nutrition Research and Practice, 1, 266–272. https://doi.org/10.4162/nrp.
2007.1.4.266.
Soung, D. Y., Patade, A., Khalil, D. A., Lucas, E. A., Devareddy, L., Greaves, K. A., &
Arjmandi, B. H. (2006). Soy protein supplementation does not cause lymphocyto-
penia in postmenopausal women. Nutrition Journal, 5, 12. https://doi.org/10.1186/
1475-2891-5-12.
Tanaka, T., Yokota, Y., Tang, H., Zaima, N., Moriyama, T., & Kawamura, Y. (2016). Anti-
Hyperglycemic Effect of a Kudzu (Pueraria lobata) Vine Extract in Ovariectomized
Mice. Journal of Nutritional Science and Vitaminology (Tokyo), 62, 341–349.
Teixeira, S. R., Tappenden, K. A., Carson, L., Jones, R., Prabhudesai, M., Marshall, W. P.,
& Erdman, J. W., Jr. (2004). Isolated soy protein consumption reduces urinary al-
bumin excretion and improves the serum lipid profile in men with type 2 diabetes
mellitus and nephropathy. Journal of Nutrition, 34, 1874–1880.
Tibi, L., Collier, A., Patrick, A. W., Clarke, B. F., & Smith, A. F. (1988). Plasma alkaline
phosphatase isoenzymes in diabetes mellitus. Clinica Chimica Acta, 177, 147–155.
Tripathi, Y. B., Shukla, R., Pandey, N., Pandey, V., & Kumar, M. (2017). An extract of
Pueraria tuberosa tubers attenuates diabetic nephropathy by upregulating matrix
metalloproteinase-9 expression in the kidney of diabetic rats. Journal of Diabetes, 9,
123–132. https://doi.org/10.1111/1753-0407.12393.
Twig, G., Afek, A., Shamiss, A., Derazne, E., Tzur, D., Gordon, B., & Tirosh, A. (2013).
White blood cells count and incidence of type 2 diabetes in young men. Diabetes Care,
36, 276–282.
Wareham, N. J., & Herman, W. H. (2016). The clinical and public health challenges of
diabetes prevention: A search for sustainable solutions. PLoS Medicine, 13, e1002097.
https://doi.org/10.1371/journal.pmed.1002097.
Wong, K. H., Li, G. Q., Li, K. M., Razmovski-Naumovski, V., & Chan, K. (2011). Kudzu
root: Traditional uses and potential medicinal benefits in diabetes and cardiovascular
diseases. Journal of Ethnopharmacology, 134, 584–607.
Xie, Y., Bowe, B., Li, T., Xian, H., Yan, Y., & Al-Aly, Z. (2018). Higher blood urea nitrogen
is associated with increased risk of incident diabetes. Kidney International, 93,
741–752. https://doi.org/10.1016/j.kint.2017.08.033.
Xu, X., Zheng, N., Chen, Z., Huang, W., Liang, T., & Kuang, H. (2016). Puerarin, isolated
from Pueraria lobata (Willd.), protects against diabetic nephropathy by attenuating
oxidative stress. Gene, 591, 411–416. https://doi.org/10.1016/j.gene.2016.06.032.
Yang, D. K., & Kang, H. S. (2018). Anti-diabetic effect of cotreatment with quercetin and
resveratrol in streptozotocin-induced diabetic rats. Biomolecules & Therapeutics
(Seoul), 26, 130–138. https://doi.org/10.4062/biomolther.2017.254.
Yang, L., Yao, D., Yang, H., Wei, Y., Peng, Y., Ding, Y., & Shu, L. (2016). Puerarin protects
pancreatic β-cells in obese diabetic mice via activation of GLP-1R signaling.Molecular
Endocrinology, 30, 361–371. https://doi.org/10.1210/me.2015-1213.
Yaribeygi, H., Mohammadi, M. T., Rezaee, R., & Sahebkar, A. (2018). Crocin improves
renal function by declining Nox-4, IL-18, and p53 expression levels in an experi-
mental model of diabetic nephropathy. Journal of Cellular Biochemistry, 119,
6080–6093.
K.C. Duru, et al. Journal of Functional Foods 68 (2020) 103922
11
